Cargando…

Central Pontine Myelinolysis Secondary to Hyperglycemia in a Young Patient

Central pontine myelinolysis (CPM) is a neurological disorder typically caused by rapid correction of severe chronic hyponatremia. Conditions causing a hyperosmolar state can also cause CPM, but it is rarely seen in diabetes. Here we describe a case of a 34-year-old female with longstanding uncontro...

Descripción completa

Detalles Bibliográficos
Autores principales: Mir, Wasey Ali Yadullahi, Shrestha, Dhan B, Aryal, Barun B, Reddy, Vijay K, Yadullahi, Mir Arshad Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569644/
https://www.ncbi.nlm.nih.gov/pubmed/34754656
http://dx.doi.org/10.7759/cureus.18495
_version_ 1784594679289872384
author Mir, Wasey Ali Yadullahi
Shrestha, Dhan B
Aryal, Barun B
Reddy, Vijay K
Yadullahi, Mir Arshad Ali
author_facet Mir, Wasey Ali Yadullahi
Shrestha, Dhan B
Aryal, Barun B
Reddy, Vijay K
Yadullahi, Mir Arshad Ali
author_sort Mir, Wasey Ali Yadullahi
collection PubMed
description Central pontine myelinolysis (CPM) is a neurological disorder typically caused by rapid correction of severe chronic hyponatremia. Conditions causing a hyperosmolar state can also cause CPM, but it is rarely seen in diabetes. Here we describe a case of a 34-year-old female with longstanding uncontrolled diabetes mellitus who presented with bilateral upper and lower limb weakness and dysphagia. Examination showed decreased muscle strength, and laboratory investigations showed high HbA1c, high blood glucose, increased serum osmolality, and normal sodium. A diagnosis of CPM was made after MRI showed restricted diffusion in the bilateral pons and CT showed pontine hypodensities. The patient was started on insulin therapy, and she showed clinical improvement with improving blood glucose levels. After five days of hospital stay, she was discharged home with appointments to neurology and endocrinology clinics. This case shows that CPM is a potential complication of uncontrolled diabetes mellitus in the presence of normal serum sodium. Timely treatment of hyperglycemia can lead to improvement of symptoms, but it is a potentially fatal condition. Thus, a diagnosis of CPM should be considered in diabetic patients who present with neurological symptoms and hyperglycemia.
format Online
Article
Text
id pubmed-8569644
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-85696442021-11-08 Central Pontine Myelinolysis Secondary to Hyperglycemia in a Young Patient Mir, Wasey Ali Yadullahi Shrestha, Dhan B Aryal, Barun B Reddy, Vijay K Yadullahi, Mir Arshad Ali Cureus Endocrinology/Diabetes/Metabolism Central pontine myelinolysis (CPM) is a neurological disorder typically caused by rapid correction of severe chronic hyponatremia. Conditions causing a hyperosmolar state can also cause CPM, but it is rarely seen in diabetes. Here we describe a case of a 34-year-old female with longstanding uncontrolled diabetes mellitus who presented with bilateral upper and lower limb weakness and dysphagia. Examination showed decreased muscle strength, and laboratory investigations showed high HbA1c, high blood glucose, increased serum osmolality, and normal sodium. A diagnosis of CPM was made after MRI showed restricted diffusion in the bilateral pons and CT showed pontine hypodensities. The patient was started on insulin therapy, and she showed clinical improvement with improving blood glucose levels. After five days of hospital stay, she was discharged home with appointments to neurology and endocrinology clinics. This case shows that CPM is a potential complication of uncontrolled diabetes mellitus in the presence of normal serum sodium. Timely treatment of hyperglycemia can lead to improvement of symptoms, but it is a potentially fatal condition. Thus, a diagnosis of CPM should be considered in diabetic patients who present with neurological symptoms and hyperglycemia. Cureus 2021-10-05 /pmc/articles/PMC8569644/ /pubmed/34754656 http://dx.doi.org/10.7759/cureus.18495 Text en Copyright © 2021, Mir et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Endocrinology/Diabetes/Metabolism
Mir, Wasey Ali Yadullahi
Shrestha, Dhan B
Aryal, Barun B
Reddy, Vijay K
Yadullahi, Mir Arshad Ali
Central Pontine Myelinolysis Secondary to Hyperglycemia in a Young Patient
title Central Pontine Myelinolysis Secondary to Hyperglycemia in a Young Patient
title_full Central Pontine Myelinolysis Secondary to Hyperglycemia in a Young Patient
title_fullStr Central Pontine Myelinolysis Secondary to Hyperglycemia in a Young Patient
title_full_unstemmed Central Pontine Myelinolysis Secondary to Hyperglycemia in a Young Patient
title_short Central Pontine Myelinolysis Secondary to Hyperglycemia in a Young Patient
title_sort central pontine myelinolysis secondary to hyperglycemia in a young patient
topic Endocrinology/Diabetes/Metabolism
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569644/
https://www.ncbi.nlm.nih.gov/pubmed/34754656
http://dx.doi.org/10.7759/cureus.18495
work_keys_str_mv AT mirwaseyaliyadullahi centralpontinemyelinolysissecondarytohyperglycemiainayoungpatient
AT shresthadhanb centralpontinemyelinolysissecondarytohyperglycemiainayoungpatient
AT aryalbarunb centralpontinemyelinolysissecondarytohyperglycemiainayoungpatient
AT reddyvijayk centralpontinemyelinolysissecondarytohyperglycemiainayoungpatient
AT yadullahimirarshadali centralpontinemyelinolysissecondarytohyperglycemiainayoungpatient